Company Profile
The Genelux Difference
Genelux is a Phase 3 biopharmaceutical company developing powerful therapeutics for patients suffering from difficult-to-treat cancers. The Company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor’s sophisticated defense mechanisms.
Equiniti Trust Company, LLC (EQ)
6201 15th Ave
Brooklyn, NY 11219
Call Center is open Monday through Friday, 8 a.m. to 8 p.m. ET.
(800) 937-5449 toll free
(718) 921-8124 international